Idaho Hematology and Breast Cancer Conference
The Idaho Hematology and Breast Cancer Conference, is a CME-accredited, in-person hematology oncology conference featuring leading hematology and breast cancer experts. Expert faculty will place key abstract findings from the 65th ASH Annual Meeting (ASH2023) and the San Antonio Breast Cancer Symposium (SABCS2023) into clinical context and discuss how the results may change the current standards of care for patients with benign and malignant hematologic disorders and breast cancer. This conference is designed to provide physicians, physician assistants, nurse practitioners, pharmacists, nurses, and other healthcare professionals with the latest updates in the field. It will highlight a multidisciplinary approach and the integration of new advances in patient-centered care.
This conference allows attendees an opportunity to discuss current research and advances in the field of hematologic disorders and breast cancer with colleagues and key opinion leaders. The goals of this conference are to review and critically assess the results of practice-changing clinical data and expert recommendations to optimize clinical outcomes for patients.
ORGANIZING COMMITTEE
Course Director:
Binay Shah, MD, MHA - Binaytara Foundation
Conference Chair:
Andrew Scott Pierson, MD- Saint Alphonsus Cancer Institute
HOTEL RESERVATION INFORMATION
A limited number of guestrooms have been booked at the Grove Hotel for attendees, exhibitors, and faculty of this meeting. Please use the link below to book your hotel room at a discounted rate of $199/night. Please book by Monday, January 8, 2024 to receive the discounted guestroom rate.
Booking link: https://reservations.travelclick.com/76224?groupID=4143982
Attendees and exhibitors can also call the hotel at 1-208-489-2222 or 1-888-961-5000 to book the rooms.
Target Audience
- Hematologists, Oncologists
- Surgeons
- Radiation Oncologists
- Physician Assistants/Nurse Practitioners
- Pharmacists
- Nurses
Learning Objectives
- Review data presented at the ASH2023 and SABCS2023 & discuss their applications in clinical settings.
- Choose new therapeutic options for treating benign and malignant hematologic disorders & breast cancer, understanding appropriate indications and contraindications to these therapeutic approaches.
- Discuss the study design and primary endpoints of recently reported and ongoing trials that have influenced the changes in the standards of care in hematology and breast cancer.
- Integrate evolving diagnostic, prognostic, and therapeutic approaches to managing hematologic disorders and breast cancer patients.
- Individualize management of patients based on emerging data from clinical trials and evolving expert guidelines.
GLOBAL ONCOLOGY PROJECT
To learn more about our ongoing project building a 200-bed cancer hospital in Nepal:
DAY 1 - FEBRUARY 9th, 2024
All times are listed in Mountain Standard Time (MST)
04:00 PM – 04:45 PM: Registration/Networking & Exhibits
04:45 PM – 05:00 PM: Opening remarks
05:00 PM – 06:30 PM: Session 1 – Case-based discussion
Moderator: Andrew Scott Pierson, MD
Case 1 – Bleeding disorder- Prakash Vishnu, MD, FACP
Case 2 – Smoldering myeloma- Aaron Goodman, MD
Case 3 – ITP- Andrew Scott Pierson, MD
Case 4 – Bone marrow failure- Anuhya Kommalapati, MD
06:30 PM – 07:15 PM: Networking/reception & Exhibits
DAY 2 - FEBRUARY 10th, 2024
07:00 AM – 08:00 AM: Breakfast & Exhibits
08:00 AM- 08:15 AM: Binaytara Foundation's Efforts in Improving Cancer Care Disparities - Binay Shah, MD
08:15 AM – 09:45 AM: Session 2
Moderator: Travis Williams, DO
08:15 AM – 08:40 AM: MDS/Acute Leukemia- Roland Walter, MD, PhD, MS
08:40 AM – 09:05 AM: Myeloproliferative neoplasms and CML- Tsewang Tashi, MD
09:05 AM – 09:30 AM: Cellular therapy in hematologic malignancies – recent updates- Swathi Namburi, MD
09:30 AM – 09:45 AM: Q & A
09:45 AM – 10:00 AM: Break & exhibits
10:00 AM – 11:45 AM: Session 3
Moderator: Clinton Morgan, MD
10:00 AM – 10:25 AM: Lymphoma- Ryan Lynch, MD
10:25 AM – 10:50 AM: Chronic lymphocytic leukemia- Alexey Danilov, MD, PHD
10:50 AM – 11:15 AM: Multiple myeloma- Rebecca Silbermann, MD, MMS
11:15 AM – 11:45 AM: Q & A
11:45 AM - 12:45 PM: Lunch & exhibits
Product Theater Sponsored by Novartis *Non CME Activity* in Ivy Room
Topic: Addressing the Needs of Patients Across the HR+/HER2- Landscape: The Role of KISQALI (Ribociclib)
Speaker: Irina Kreyman, Director P2P Breast and Women’s Cancer at Novartis
12:45 PM - 02:30 PM: Session 4
Moderator: Stephanie Hodson, MD
12:45 PM - 01:10 PM: Hormone receptor positive breast cancer- Mei Wei, MD
01:10 PM - 01:35 PM: HER2 positive breast cancer- David Page, MD
01:35 PM - 02:00 PM: Triple negative and HER2 low breast cancer- Christos Vaklavas, MD
02:00 PM – 02:30 PM: Q & A
02:30 PM – 02:45 PM: Break & exhibits
02:45 PM – 04:30 PM: Session 5
Moderator: Elizabeth Prier, MD FACS
02:45 PM – 03:10 PM: Radiotherapy – best breast practice- Camille Berriochoa, MD
03:10 PM – 03:35 PM: Updates in surgical approach – best breast practice- Kshama Jaiswal, MD, FACS
03:35 PM – 03:50 PM: Q & A
03:50 PM – 04:30 PM: Case-based discussion
Case 1 – DCIS- Gliceida Galarza Fortuna, MD
Case 2 – Inflammatory breast cancer- Wendy Wang, MD, PhD
Case 3 – Early Stage breast cancer- Laura Miotke, MD
04:30 PM – 04:35 PM: Adjourn
Booking link: https://reservations.travelclick.com/76224?groupID=4143982
Book your rooms by January 8th to receive a discounted rate of $199 at night.
Attendees and exhibitors can also call the hotel at 1-208-489-2222 or 1-888-961-5000 to book the rooms.
IDENTIFICATION AND MITIGATION OF POTENTIAL CONFLICT OF INTERESTS:
All conflict of interest has been identified and mitigated for individuals in control of contents.
PLANNING COMMITTEE DISCLOSURE STATEMENT:
None of the members of the planning committee, nor any member of their immediate families, have a relevant financial interest in or affiliation with any commercial supporter of this educational activity and/or with the manufacturer(s) of commercial products and/or providers of any commercial services discussed in this educational activity.
Binay Shah, MD, MHA
Andrew Pierson, MD
Camille Berriochoa
Alexey Danilov, MD, PhD
Kshama Jaiswal
Ryan Lynch
Swathi Namburi, MD
David Page, MD
Rebecca Silbermann, MD, MMS
Tsewang Tashi
Christos Vaklavas, M.D., Associate Professor
Roland Walter, MD PhD MS
Mei Wei, MD
Gliceida Galarza Fortuna
Aaron Goodman, MD
Anuhya Kommalapati, MD
Laura Miotke
Prakash Vishnu, MD, FACP
Xiaowen Wang, MD, PhD
Stephanie Hodson, MD, FACP
Clinton Morgan
Elizabeth Prier, MD
Travis Williams
Available Credit
- 8.25 ABIM MOC IISuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8.25 Medical Knowledge points in the American Board of Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
- 8.25 AMA PRA Category 1 Credit™The Binaytara Foundation is accredited by the Washington State Medical Association to provide continuing medical education for physicians. The Binaytara Foundation designates this live activity for a maximum of 8.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This activity meets the criteria for up to 8.25 hours of Category I CME credit to satisfy the relicensure requirements of the Washington State Medical Quality Assurance Commission.
- 8.25 Nursing Contact HoursProvider approved by the California Board of Registered Nursing, Provider # CEP17035, for 8.25 Contact Hours.
If you are interested in exhibiting at this meeting, please visit our exhibit page here - https://education.binayfoundation.org/exhibit-information
Price
POLICY ON INDUSTRY EMPLOYEE'S PARTICIPATION IN MARKETING/EDUCATION ACTIVITY AT THE CONFERENCE:
All marketing and product promotion activities must occur in the designated exhibit hall or product theater space separate from the area where this accredited continuing education takes place.
The exhibit and product promotion space is reserved only for companies that have purchased marketing and product promotion slots at the conference. The individual registration fee doesn't include marketing or product theater privileges. Please refer to the sponsorship handbook for the types of marketing activities included in your display/sponsorship fees.
If your company has NOT purchased a marketing opportunity such as an exhibit table, product theater slot or another type of marketing opportunity, you may not participate in any marketing activity or attempt to educate healthcare providers about your product or service. Industry attendees of companies without marketing opportunities must refrain from interacting with healthcare providers at this meeting in any form, including introducing themselves as an employee of the company, discussing the care of patients, handing out flyers and brochures, inviting participants to the company's other programs, etc.
Violating this policy will result in a fine equivalent to a general display fee for that conference.
If your company has purchased an exhibit or sponsorship, please register at the link below to receive the discounted registration fees:
Link to register as an additional rep of a sponsoring company: https://education.
NOTICE TO HCPS EMPLOYED BY THE INDUSTRY:
If you are employed by industry, including pharmaceuticals and biotech companies, you must pay the INDUSTRY REGISTRATION FEE to participate in any meeting organized by the Binaytara Foundation. If you misrepresented yourself as a healthcare provider not employed by the industry and failed to pay the Industry registration fee, the following fees apply:
- If your company has purchased a display table at the event, you will be billed the full INDUSTRY REGISTRATION FEE plus a fine equivalent to the full industry registration fee for that event = 2 X the industry registration fee.
- If your company has NOT purchased a display table at the event AND you attended the meeting without paying a full industry registration fee, you will be billed a full GENERAL DISPLAY FEE for that event.
- If your company has NOT purchased a display table at the event AND you attended the meeting paying a full industry registration fee, BUT YOU PARTICIPATED IN MARKETING AND PROMOTIONAL ACTIVITIES, you will be billed a full GENERAL DISPLAY FEE for that event.
Any outstanding display fee, registration fee, and fines must be paid before the industry employee or the company will be able to attend/display at our conferences again.
CANCELLATION POLICY
You may cancel your enrollment at any time. Cancellation fees apply as below:
- 50% of the paid registration fee will be refunded if registration is canceled six weeks before the conference.
- No refunds will be issued if registration is canceled after that date.
No credits will be offered if you do not complete all required steps of this activity, including registration and participation in the live meeting.